How can citizens support mifepristone access if Trump administration attempts new restrictions?

Question

Accepted Answer

Filing public comments on FDA's REMS program citing 25 years of safety data creates an administrative record that strengthens legal challenges to any future restrictions. When the FDA proposes REMS changes, it must open a public comment period under the Administrative Procedure Act. Comments citing peer-reviewed studies, international data, and existing FDA findings become part of the official record. If the FDA then restricts access despite contradictory evidence in its own files, courts can strike down the rule as "arbitrary and capricious"—the legal standard requiring agencies to justify decisions with evidence.

How can citizens support mifepristone access if Trump administration attempts new restrictions?

Explanation

Related Questions